Skip to main content
Fig. 6 | Molecular Medicine

Fig. 6

From: Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time

Fig. 6

CD4+ T cells of DR-TB have decreased TNFR1, TGFβ1, and FOXP3 gene expression, even though TNF, TNFR2, and EBi3 expression is up-regulated at the transcriptional level. We calculated the fold change percentage of expression of TNF (A), TNFR1 (B), TNFR2 (C), TGFβ1 (D), FOXP3 (E), and EBi3 (F). The percentage of fold change was calculated by obtaining the difference between six months and before of anti-TB therapy per each group. DS-TB n = 3, DR-TB n = 3. Data are shown in bar graphs with median values

Back to article page

Molecular Medicine

ISSN: 1528-3658